Page last updated: 2024-08-17

alloxan and kainic acid

alloxan has been researched along with kainic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonhomme, N; Casara, P; Dorey, G; Lestage, P; Lockhart, B; Roger, A	1
Dohovics, R; Janáky, R; Oja, SS; Saransaari, P; Varga, V	1

Other Studies

2 other study(ies) available for alloxan and kainic acid

Article	Year
Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration. European journal of pharmacology, 2001, Mar-23, Volume: 416, Issue:1-2 Topics: Alloxan; Animals; Antioxidants; Body Temperature; Brain Ischemia; Cell Survival; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Hyperglycemia; Injections, Intraventricular; Kainic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nerve Degeneration; Neurons; Quinolines; Rats; Rats, Wistar; Rectum; Survival Rate; tert-Butylhydroperoxide	2001
Changes in intracellular cyclic AMP formation mask opposing modulation of kainate-enhanced glutamate release in the striatum. Proceedings of the Western Pharmacology Society, 2004, Volume: 47 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adrenergic beta-Agonists; Alloxan; Animals; Aspartic Acid; Cyclic AMP; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Isoproterenol; Kainic Acid; Kinetics; Mice; Neostriatum; Phenethylamines	2004

Article

Year

Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration.

European journal of pharmacology, 2001, Mar-23, Volume: 416, Issue:1-2

Topics: Alloxan; Animals; Antioxidants; Body Temperature; Brain Ischemia; Cell Survival; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Hyperglycemia; Injections, Intraventricular; Kainic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nerve Degeneration; Neurons; Quinolines; Rats; Rats, Wistar; Rectum; Survival Rate; tert-Butylhydroperoxide

2001

Changes in intracellular cyclic AMP formation mask opposing modulation of kainate-enhanced glutamate release in the striatum.

Proceedings of the Western Pharmacology Society, 2004, Volume: 47

Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adrenergic beta-Agonists; Alloxan; Animals; Aspartic Acid; Cyclic AMP; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Isoproterenol; Kainic Acid; Kinetics; Mice; Neostriatum; Phenethylamines

2004